An Expanded Access Protocol for Apalutamide Treatment of Participants With Non-Metastatic Castration-Resistant Prostate Cancer

NCT03523338 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Prostatic Neoplasms

Interventions

DRUG: Apalutamide
DRUG: ADT (Standard of Care)

Sponsor

Aragon Pharmaceuticals, Inc.